| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |